Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium

S. Schaefer, R. A. Lange, D. P. Gutekunst, R. W. Parkey, J. T. Willerson, Ronald M Peshock

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Contrast-enhanced magnetic resonance (MR) imaging can define myocardial perfusion defects due to acute coronary occlusion. However, since most clinically important diagnostic examinations involve coronary arteries with subtotal stenoses, we investigated the ability of MR imaging with a manganese contrast agent to detect perfusion abnormalities in a canine model of partial coronary artery stenosis. The contrast agent was administered after the creation of a partial coronary artery stenosis with the addition of the coronary vasodilator dipyridamole in six of 12 animals. The hearts were imaged ex situ using gradient reversal and spin-echo sequences, and images were analyzed to determine differences in signal intensity between hypoperfused and normally perfused myocardium. Comparison of MR images with regional blood flow and thallium-201 measurements showed good concordance of hypoperfused segments in those animals given dipyridamole, with 75% of the abnormal segments correctly identified. In those animals not given dipyridamole, 48% of segments were correctly identified. Thus, ex vivo MR imaging with a paramagnetic contrast enhancement can be used to detect acute regional myocardial perfusion abnormalities due to severe partial coronary artery stenoses.

Original languageEnglish (US)
Pages (from-to)551-556
Number of pages6
JournalInvestigative Radiology
Volume26
Issue number6
StatePublished - 1991

Fingerprint

Dipyridamole
Coronary Stenosis
Myocardium
Perfusion
Magnetic Resonance Imaging
Contrast Media
Thallium
Coronary Occlusion
Regional Blood Flow
Manganese
Vasodilator Agents
Canidae
Coronary Vessels
Pathologic Constriction
Magnetic Resonance Spectroscopy

Keywords

  • Contrast agents
  • Magnetic resonance imaging
  • Manganese
  • Myocardial ischemia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Schaefer, S., Lange, R. A., Gutekunst, D. P., Parkey, R. W., Willerson, J. T., & Peshock, R. M. (1991). Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Investigative Radiology, 26(6), 551-556.

Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. / Schaefer, S.; Lange, R. A.; Gutekunst, D. P.; Parkey, R. W.; Willerson, J. T.; Peshock, Ronald M.

In: Investigative Radiology, Vol. 26, No. 6, 1991, p. 551-556.

Research output: Contribution to journalArticle

Schaefer, S, Lange, RA, Gutekunst, DP, Parkey, RW, Willerson, JT & Peshock, RM 1991, 'Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium', Investigative Radiology, vol. 26, no. 6, pp. 551-556.
Schaefer S, Lange RA, Gutekunst DP, Parkey RW, Willerson JT, Peshock RM. Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. Investigative Radiology. 1991;26(6):551-556.
Schaefer, S. ; Lange, R. A. ; Gutekunst, D. P. ; Parkey, R. W. ; Willerson, J. T. ; Peshock, Ronald M. / Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium. In: Investigative Radiology. 1991 ; Vol. 26, No. 6. pp. 551-556.
@article{95d1f2a898fd4cc4bb26a9a5f868fb44,
title = "Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium",
abstract = "Contrast-enhanced magnetic resonance (MR) imaging can define myocardial perfusion defects due to acute coronary occlusion. However, since most clinically important diagnostic examinations involve coronary arteries with subtotal stenoses, we investigated the ability of MR imaging with a manganese contrast agent to detect perfusion abnormalities in a canine model of partial coronary artery stenosis. The contrast agent was administered after the creation of a partial coronary artery stenosis with the addition of the coronary vasodilator dipyridamole in six of 12 animals. The hearts were imaged ex situ using gradient reversal and spin-echo sequences, and images were analyzed to determine differences in signal intensity between hypoperfused and normally perfused myocardium. Comparison of MR images with regional blood flow and thallium-201 measurements showed good concordance of hypoperfused segments in those animals given dipyridamole, with 75{\%} of the abnormal segments correctly identified. In those animals not given dipyridamole, 48{\%} of segments were correctly identified. Thus, ex vivo MR imaging with a paramagnetic contrast enhancement can be used to detect acute regional myocardial perfusion abnormalities due to severe partial coronary artery stenoses.",
keywords = "Contrast agents, Magnetic resonance imaging, Manganese, Myocardial ischemia",
author = "S. Schaefer and Lange, {R. A.} and Gutekunst, {D. P.} and Parkey, {R. W.} and Willerson, {J. T.} and Peshock, {Ronald M}",
year = "1991",
language = "English (US)",
volume = "26",
pages = "551--556",
journal = "Investigative Radiology",
issn = "0020-9996",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Contrast-enhanced magnetic resonance imaging of hypoperfused myocardium

AU - Schaefer, S.

AU - Lange, R. A.

AU - Gutekunst, D. P.

AU - Parkey, R. W.

AU - Willerson, J. T.

AU - Peshock, Ronald M

PY - 1991

Y1 - 1991

N2 - Contrast-enhanced magnetic resonance (MR) imaging can define myocardial perfusion defects due to acute coronary occlusion. However, since most clinically important diagnostic examinations involve coronary arteries with subtotal stenoses, we investigated the ability of MR imaging with a manganese contrast agent to detect perfusion abnormalities in a canine model of partial coronary artery stenosis. The contrast agent was administered after the creation of a partial coronary artery stenosis with the addition of the coronary vasodilator dipyridamole in six of 12 animals. The hearts were imaged ex situ using gradient reversal and spin-echo sequences, and images were analyzed to determine differences in signal intensity between hypoperfused and normally perfused myocardium. Comparison of MR images with regional blood flow and thallium-201 measurements showed good concordance of hypoperfused segments in those animals given dipyridamole, with 75% of the abnormal segments correctly identified. In those animals not given dipyridamole, 48% of segments were correctly identified. Thus, ex vivo MR imaging with a paramagnetic contrast enhancement can be used to detect acute regional myocardial perfusion abnormalities due to severe partial coronary artery stenoses.

AB - Contrast-enhanced magnetic resonance (MR) imaging can define myocardial perfusion defects due to acute coronary occlusion. However, since most clinically important diagnostic examinations involve coronary arteries with subtotal stenoses, we investigated the ability of MR imaging with a manganese contrast agent to detect perfusion abnormalities in a canine model of partial coronary artery stenosis. The contrast agent was administered after the creation of a partial coronary artery stenosis with the addition of the coronary vasodilator dipyridamole in six of 12 animals. The hearts were imaged ex situ using gradient reversal and spin-echo sequences, and images were analyzed to determine differences in signal intensity between hypoperfused and normally perfused myocardium. Comparison of MR images with regional blood flow and thallium-201 measurements showed good concordance of hypoperfused segments in those animals given dipyridamole, with 75% of the abnormal segments correctly identified. In those animals not given dipyridamole, 48% of segments were correctly identified. Thus, ex vivo MR imaging with a paramagnetic contrast enhancement can be used to detect acute regional myocardial perfusion abnormalities due to severe partial coronary artery stenoses.

KW - Contrast agents

KW - Magnetic resonance imaging

KW - Manganese

KW - Myocardial ischemia

UR - http://www.scopus.com/inward/record.url?scp=0025743064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025743064&partnerID=8YFLogxK

M3 - Article

VL - 26

SP - 551

EP - 556

JO - Investigative Radiology

JF - Investigative Radiology

SN - 0020-9996

IS - 6

ER -